{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:46:30Z","timestamp":1792118790803,"version":"4.4.0"},"reference-count":75,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>Tuberculosis (TB) treatment has changed little in the past 40 years. The current standard therapy requires four drugs for 2 months followed by two drugs for 4 months. This \u201cshort\u2010course\u201d regimen is not based on optimized pharmacokinetic and pharmacodynamic properties, but empiric evidence. A review of existing data suggests that pharmacokinetic variability with isoniazid and rifampin is greater than previously thought, and that efficacy is not as good as traditionally reported. Adding new drugs to the current regimen will be costly and time\u2010consuming. Maximizing the efficacy of the current medications is a less expensive and more feasible option. This article reviews the current potential of the first\u2010line TB drugs (rifamycins, isoniazid, pyrazinamide, and ethambutol) as well as the fluoroquinolones to introduce a true short\u2010course TB regimen.<\/jats:p>","DOI":"10.1002\/cpt.180","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T08:47:36Z","timestamp":1435826856000},"page":"387-393","source":"Crossref","is-referenced-by-count":44,"title":["Optimizing the clinical pharmacology of tuberculosis medications"],"prefix":"10.1111","volume":"98","author":[{"given":"EF","family":"Egelund","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research College of Pharmacy University of Florida Gainesville Florida USA"},{"name":"Infectious Disease Pharmacokinetics Laboratory University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alsultan","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research College of Pharmacy University of Florida Gainesville Florida USA"},{"name":"Infectious Disease Pharmacokinetics Laboratory University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"Peloquin","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research College of Pharmacy University of Florida Gainesville Florida USA"},{"name":"Infectious Disease Pharmacokinetics Laboratory University of Florida Gainesville Florida USA"},{"name":"Emerging Pathogens Institute University of Florida Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"key":"e_1_2_13_1_1","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.99.10.531"},{"key":"e_1_2_13_2_1","first-page":"471","article-title":"Controlled clinical trial of four 6\u2010month regimens of chemotherapy for pulmonary tuberculosis. Second Report","volume":"114","author":"Second East African\/British Medical Research Council Study","year":"1976","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(79)90001-1"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-4-199708150-00006"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit352"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1610.100374"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01533-06"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2118-2124.2003"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666140901215544"},{"key":"e_1_2_13_10_1","volume-title":"ClinicalTrials.gov [Internet]","author":"Medicine HUFo","year":"2000"},{"key":"e_1_2_13_11_1","unstructured":"Savic R.W.et al.Pharmacokinetic\u2010pharmacodynamic analysis of rifapentine in patients during intensive phase treatment for tuberculosis from Tuberculosis Trial Consortium Studies 29 and 29X. In: 6th International Workshop on Pharmacology of Tuberculosis Drugs. Denver CO;2013."},{"key":"e_1_2_13_12_1","volume-title":"ClinicalTrials.gov [Internet]","author":"Padjadjaran U.","year":"2000"},{"key":"e_1_2_13_13_1","first-page":"923","article-title":"Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.","volume":"98","author":"Verbist L.","year":"1968","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00912-12"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir184"},{"key":"e_1_2_13_16_1","first-page":"71","article-title":"Two three\u2010month treatment regimens for pulmonary tuberculosis.","volume":"51","author":"Kreis B.","year":"1976","journal-title":"Bull. Int. Union Tuberc."},{"key":"e_1_2_13_17_1","first-page":"3","article-title":"What is the \u2018right\u2019 dose of rifampin?","volume":"7","author":"Peloquin C.","year":"2003","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560802694564"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01550-06"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0222-8"},{"key":"e_1_2_13_21_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5588\/09640569513002","article-title":"Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia.","volume":"6","author":"Crevel R.","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1178"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.12.2670"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000220750"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/507543"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/599040"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/322706"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140050-00002"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102s9101"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05792-11"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1029OC"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis461"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00500-12"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.2073"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01730-13"},{"key":"e_1_2_13_36_1","first-page":"732","article-title":"Disposition and metabolism of 14C\u2010rifapentine in healthy volunteers.","volume":"26","author":"Reith K.","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200311-1612OC"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01918-13"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(97)00071-9"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1086\/496980"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1572-1577.2001"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05467.x"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.3.9609132"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.2951-2957.2004"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq374"},{"key":"e_1_2_13_46_1","volume-title":"AHFS drug information","year":"2006"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-951OC"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.5.1733-1738.2005"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1429-9"},{"key":"e_1_2_13_50_1","unstructured":"Primary Anti\u2010TB Drug Resistance United States 1993\u20132011. Centers for Disease Control. <http:\/\/www.cdc.gov\/tb\/statistics\/surv\/surv2011\/slides\/surv19.htm> (2011). Accessed 1 May2015."},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2484"},{"key":"e_1_2_13_52_1","first-page":"1360","article-title":"Pharmacokinetics of ethambutol in children and adults with tuberculosis.","volume":"8","author":"Zhu M.","year":"2004","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.167.4.603"},{"key":"e_1_2_13_54_1","first-page":"939","article-title":"The early bactericidal activity of drugs in patients with pulmonary tuberculosis.","volume":"121","author":"Jindani A.","year":"1980","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1966.tb45528.x"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/79558"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2011.05.006"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01681-08"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03931-14"},{"key":"e_1_2_13_60_1","first-page":"319","article-title":"Pyrazinamide\u2010isoniazid in tuberculosis.","volume":"69","author":"McDermott W.","year":"1954","journal-title":"Am. Rev. Tuberc."},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01567-09"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00239-X"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01036-07"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01621-06"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200407-885OC"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407426"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067030"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1086\/424849"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313865"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06126-11"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00125812"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112433"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61080-0"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.03.002"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094462"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.180","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:28:42Z","timestamp":1699363722000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1002\/cpt.180"],"URL":"https:\/\/doi.org\/10.1002\/cpt.180","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]}}}